Global cancer biomarkers market size to growing at 11.8% CAGR through 2027

According to the report titled ‘Global Cancer Biomarkers Market Size study, by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics-based Tests), by Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Others), by Application (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others) and Regional Forecasts 2020-2027’, available with Market Study Report LLC, global cancer biomarkers market was worth USD 10.9 billion in 2019 and is expected to grow with a CAGR of 11.8% during 2020-2027.

Rising number of cancer patients, growing awareness regarding cancer therapy, and increasing investment & government funding in product development are the key factors driving the global cancer biomarkers market growth. As per the World Health Organization (WHO) data published in 2018, cancer is the second leading cause of death worldwide, with approximately 70% of cancer mortality occurring in developed and developing economies. Similarly, according to International Agency for Research on Cancer (IARC), 9.6 million cancer deaths and 18.1 million new cancer cases were recorded across the globe in 2018. In addition, the world is expected to record 27.5 million new cases of cancer and about 16.3 million deaths owing to cancer by the year 2040.  

For those uninitiated, a traceable substance which indicates the presence of cancerous cells in the human body is a cancer biomarker. A biomarker may be a tumor-covered molecule or a specific human body response to the existence of cancerous cells. Improved cognizance about benefits of early diagnosis of cancer among individuals, in tandem with ability of biomarkers to provide quick results enabling clinicians to take informed treatment decisions are bolstering the market remuneration.

Request Sample copy of this Report @ https://www.marketstudyreport.com/request-a-sample/2895871/

However, unregularized government norms and reimbursement policies along with hefty cost of vaccine development are likely to hinder the industry landscape over the study period.

Citing the regional landscape, worldwide cancer biomarkers market sphere is segmented into North America, Asia Pacific, Latin America, Europe, and Rest of the World. The report claims that North America currently accounts for a significant market share and is projected to grow further over the analysis period. The regional growth is attributable to concentration of major players and increasing use of cancer biomarkers in drug discovery & development.

Meanwhile, Asia Pacific cancer biomarkers industry is expected to register a decent growth rate through 2027, on account of improving healthcare infrastructure in developing economies like India and China, along with rising pervasiveness of cancer.

Leading organizations influencing global cancer biomarkers market dynamics are F. Hoffmann-La Roche Ltd., PerkinElmer Inc., Siemens AG, Abbott Laboratories, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Qiagen N.V., Merck KGaA, Exact Sciences Corporation, and Bristol-Myers Squibb Company.

To access a sample pages of this report titled “Global Cancer Biomarkers Market Size study, by Profiling Technology (Omic Technologies, Imaging Technologies, Immunoassays, Cytogenetics-based Tests), by Biomolecule (Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers), by Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Stomach Cancer, Others), by Application (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others) and Regional Forecasts 2020-2027” in detail along with the table of contents, please click the link below:

https://www.marketstudyreport.com/reports/global-cancer-biomarkers-market-size-research

Related Report:

Global Prostate Cancer Therapeutics Market Size study and Regional Forecasts 2020-2027

Global Prostate Cancer Therapeutics Market is valued approximately at USD 9.9 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 7.68% over the forecast period 2020-2027. According to data released by the World Cancer Research Fund International, more than 1.1 million cases of prostate cancer have been registered in 2012, accounting for around 8 percent of the total tumor cases. Although the exact cause of prostate cancer is not known, the factors associated with it include overweight, obesity, and the history of any other tumor growth. And patients with cardiovascular disease are vulnerable to cancer metastases. As a result, the rising incidence rate of the above-mentioned conditions is driving market growth.

About US:

Market Study Report, LLC. is a hub for market intelligence products and services.

We streamline the purchase of your market research reports and services through a single integrated platform by bringing all the major publishers and their services at one place.

Our customers partner with Market Study Report, LLC. to ease their search and evaluation of market intelligence products and services and in turn focus on their company's core activities.

If you are looking for research reports on global or regional markets, competitive information, emerging markets and trends or just looking to stay on top of the curve then Market Study Report, LLC. is the platform that can help you in achieving any of these objectives.

Contact Us:

 
Corporate Sales,
Market Study Report LLC
Phone: 1-302-273-0910
Toll Free: 1-866-764-2150
Email: sales@marketstudyreport.com

News: http://business-newsupdate.com/

Back to news